Emer R McGrath

Prof. Emer R McGrath

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2017 in Neurology
Verified
Journal Article
Closed access
PDF file
EMEmer R McGrath
Emer R McGrath
ABAlexa S. Beiser
Alexa S. Beiser
CDCharles DeCarli
Charles DeCarli
KPKendra L. Plourde
Kendra L. Plourde
RVRamachandran S. Vasan
Ramachandran S. Vasan
SSSudha Seshadri
Sudha Seshadri
Objective: To determine the association between blood pressure during midlife (40–64 years) to late life (≥65 years) and risk of incident dementia. Methods: This study included 1,440 (758 women, mean age 69 ± 6 years) Framingham Offspring participants who were free of dementia and attended 5 consecutive examinations at 4-year intervals starting at midlife (1983–1987, mean age 55 years) until late life (1998–2001, mean 69 years) and subsequently were followed up for incident dementia (mean 8 years). We determined the effect of midlife hypertension (≥140/90 mm Hg), late life hypertension, lower late life blood pressure (<100/70 mm Hg), persistence of hypertension during mid- to late life, and steep decline in blood pressure from mid- to late life over an 18-year exposure period. Results: During the follow-up period, 107 participants (71 women) developed dementia. Using multivariable Cox proportional hazards models, we found that midlife systolic hypertension (hazard ratio [HR] 1.57, 95% confidence interval [CI] 1.05–2.35) and persistence of systolic hypertension into late life (HR 1.96, 95% CI 1.25–3.09) were associated with an elevated risk of incident dementia. However, in individuals with low to normal blood pressure (≤140/90 mm Hg) at midlife, a steep decline in systolic blood pressure during mid- to late life was also associated with a >2-fold increase in dementia risk (HR 2.40, 95% CI 1.39–4.15). Conclusions: Elevated blood pressure during midlife, persistence of elevated blood pressure into late life, and, among nonhypertensives, a steep decline in blood pressure during mid- to late life were associated with an increased dementia risk in a community-based cohort. Our data highlight the potential sustained cognitive benefits of lower blood pressures in midlife but also suggest that declining blood pressure in older adults with prehypertension or normotension, but not in those with hypertension, may be a risk marker for dementia.

27 August 2013 in Neurology
Verified
Journal Article
Closed access
PDF file
EMEmer R McGrath
Emer R McGrath
MKMoira K. Kapral
Moira K. Kapral
JFJiming Fang
Jiming Fang
JEJohn W. Eikelboom
John W. Eikelboom
AOAengus O’conghaile
Aengus O’conghaile
OROn behalf of the Investigators of the Ontario Stroke Registry
On behalf of the Investigators of the Ontario Stroke Registry
Objective: We determined whether patient characteristics (age, sex, comorbidities), stroke severity, and quality of care explained a proportion of the association between atrial fibrillation (AF) and increased disability and mortality in patients with acute ischemic stroke. Methods: The study included a prospective cohort of consecutive patients admitted with acute ischemic stroke included in the Registry of the Canadian Stroke Network (July 1, 2003 to March 31, 2008). Multivariable logistic regression analyses were used to determine the magnitude of association between AF and modified Rankin score 4–5 at discharge, 30-day mortality, and 1-year mortality. Results: There were 10,528 patients admitted with acute ischemic stroke. AF was associated with an increased risk of severe disability and mortality, but the magnitude of association was substantially attenuated in the full multivariable models: modified Rankin score 4–5 at discharge (univariate odds ratio [OR] 1.74, 95% confidence interval [CI] 1.57–1.93; multivariable OR 1.19, 95% CI 1.03–1.36), 30-day mortality (univariate OR 2.52, 95% CI 2.25–2.84; multivariable OR 1.36, 95% CI 1.17–1.58), and 1-year mortality (univariate OR 2.41, 95% CI 2.19–2.66; multivariable OR 1.25, 95% CI 1.10–1.42). Older age and increased stroke severity explained most of the association between AF and poor stroke outcomes. We found no association between AF and poor stroke outcomes in patients receiving therapeutic preadmission oral anticoagulant therapy. Conclusions: Older age and increased stroke severity explain most of the association between AF and poorer outcomes after acute ischemic stroke. Nonuse of oral anticoagulant therapy represents the most important modifiable care gap to mitigate the association between AF and poor outcomes after ischemic stroke.

12 November 2012 in Archives of internal medicine (1960)
Verified
Journal Article
Closed access
PDF file
MOMartin J. O’dOnnell
Martin J. O’dOnnell
JFJiming Fang
Jiming Fang
CDCami D’uva
Cami D’uva
GSGustavo Saposnik
Gustavo Saposnik
LGLinda Gould
Linda Gould
MKMoira K. Kapral
Moira K. Kapral
Research from JAMA Internal Medicine — The PLAN Score — A Bedside Prediction Rule for Death and Severe Disability Following Acute Ischemic Stroke

16 October 2018 in Neurotherapeutics
Verified
Journal Article
Closed access
PDF file
EMEmer R McGrath
Emer R McGrath
CDChristopher T. Doughty
Christopher T. Doughty
AAAnthony A. Amato
Anthony A. Amato

19 January 2017 in American Journal of Hypertension
Verified
Journal Article
Open access
PDF file
EMEmer R McGrath
Emer R McGrath
CEColin A. Espie
Colin A. Espie
APAlice Power
Alice Power
AMAndrew W. Murphy
Andrew W. Murphy
JNJohn Newell
John Newell
MOMartin J. O’dOnnell
Martin J. O’dOnnell
BACKGROUND: Impaired sleep quality is common and associated with an increased risk of cardiovascular disease (CVD), thought to be mediated through adverse effects on established vascular risk factors, particularly hypertension. We determined if a web-delivered sleep intervention (sleep–hygiene education, stimulus control, and cognitive behavioral therapy) reduces blood pressure compared to vascular risk factor education (standard care) alone. METHODS: Phase II randomized, blinded, controlled trial of 134 participants without CVD with mild sleep impairment and blood pressure 130–160/<110 mm Hg. The primary outcome was the difference in the mean change in 24-hour ambulatory systolic blood pressure (SBP) over 8 weeks between intervention and control groups. Secondary outcomes included measures of sleep quality and psychosocial health, namely Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI). RESULTS: Participants in the sleep intervention group showed significantly greater improvements in sleep quality, including ISI [difference in mean improvement 2.8; 95% confidence interval (CI), 1.3–4.4], PSQI (1.1; 95% CI, 0.1–2.2), sleep condition indicator (0.8; 95% CI, 0.2–1.4), and psychosocial health, including BDI (2.0; 95% CI, 0.3–3.7) and BAI (1.4; 95% CI, 0.02–2.8). The mean improvement in 24-hour ambulatory SBP did not differ between the sleep intervention (0.9 mm Hg) and control (0.8 mm Hg) arms, (difference in mean improvement 0.1; 95% CI, −3.4 to 3.2). CONCLUSION: A simple, low-cost, web-delivered sleep intervention is feasible and significantly improves sleep quality and measures of psychosocial health in individuals with mild sleep impairment but does not result in short-term improvements in blood pressure.

12 July 2022 in Neurology
Verified
Journal Article
Closed access
PDF file
EMEmer R McGrath
Emer R McGrath
ABAlexa S. Beiser
Alexa S. Beiser
AOAdrienne O'DOnnell
Adrienne O'DOnnell
JHJayandra J. Himali
Jayandra J. Himali
MPMatthew P. Pase
Matthew P. Pase
SSSudha Seshadri
Sudha Seshadri
Background and Objectives The association between vascular risk factors and dementia varies with age, making generalizability of dementia risk prediction rules to individuals of different ages challenging. We determined the most important vascular risk factors for inclusion in age-specific dementia risk scores. Methods Framingham Heart Study Original and Offspring cohort participants with available data on the Framingham Stroke Risk Profile (FSRP) at midlife (age 55; n = 4,899, 57% women), late life (ages 65 or 70), or later life (ages 75 or 80 [n = 2,386, 62% women]) were followed for 10-year incident dementia risk from ages 65, 70, 75, and 80. Results Age- and sex-adjusted midlife risk factors associated with 10-year risk of dementia from age 65 included FSRP (hazard ratio [HR] 1.16, 95% CI 1.06–1.26, per 1 SD increment in log-transformed score), diabetes mellitus (DM; HR 4.31, 95% CI 1.97–9.43), and systolic blood pressure (SBP; HR 1.12, 95% CI 1.02–1.24, per 10 mm Hg increment). Late-life risk factors associated with 10-year incident dementia from ages 65 or 70 included FSRP (age 65 only: HR 1.06, 95% CI 1.02–1.10), antihypertensive use (age 65 reported: HR 1.66, 95% CI 1.12–2.46), DM (age 65 reported: HR 1.96, 95% CI 1.09–3.52), atrial fibrillation (age 65 reported: HR 2.30, 95% CI 1.00–5.27), nonstroke cardiovascular disease (nsCVD; age 65 reported: HR 1.95, 95% CI 1.24–3.07), and stroke (age 70 only: HR 3.61, 95% CI 2.21–5.92). Later-life risk factors associated with 10-year incident dementia from ages 75 or 80 included antihypertensive use (age 80 only: HR 0.74, 95% CI 0.62–0.89), DM (age 80 reported: HR 1.40, 95% CI 1.04–1.89), atrial fibrillation (age 80 reported: HR 1.43, 95% CI 1.07–1.92), and stroke (age 80 reported: HR 1.63, 95% CI 1.13–2.35). In stepwise models, SBP and DM at age 55, nsCVD at age 65, DM and stroke at ages 70 and 75, and DM, stroke, and use of antihypertensives (protective) at age 80 were the most important vascular risk factors for dementia. Discussion Our findings support the use of age-specific dementia risk scores, which should prioritize including, at age 55, SBP and DM; at age 65, nsCVD; at ages 70 and 75, DM and stroke; and at age 80, DM, stroke, and antihypertensive use.